Healthtech Investors & VC Firms in North America
2650 firms in this list, with a median first check of $500K. 645 of them lead rounds. Generated from verified public data and updated continuously.
9Yards Capital
New YorkSeries A–Growth$100K – $10M
6 people
Adjuvant Capital
New YorkSeries A–Late Stage$10M – $25M
18 people
ECP Growth
GreenwichGrowth
15 people
Start Codon
CambridgePre-Seed–Seed
24 people
Delos Capital
CambridgeSeed–Growth
17 people
L'ATTITUDE Ventures
Los AngelesPre-Seed–Series A$1M – $3M
17 people
Z21 Ventures
San Francisco Bay AreaPre-Seed–Series A$500K – $1M
11 people
Amplify Capital
TorontoPre-Seed–Series A$365K – $730K
13 people
Sutter Hill Ventures
Palo AltoSeed–Late Stage$100K – $5M
10 people
Ansa Capital
New YorkSeries A–Series B$5M – $15M
6 people
Eckuity
CypressGrowth
24 people
Starting Line
ChicagoPre-Seed–Series A$750K – $2M
6 people
Oberland Capital
New YorkGrowth–Late Stage$50M – $300M
20 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
17 people
Lauder Partners
Los AltosSeries B
1 person
Carousel
CharlotteGrowth
19 people
Epidarex Capital
BethesdaSeed–Series A$2.5M – $6.3M
13 people
quadraScope Venture Fund
Boston
25 people
Yamaha Motor Ventures
Palo AltoSeed–Growth$1M – $3M
13 people
MK Capital
NorthfieldSeed–Growth$2M – $10M
6 people
Rocana Ventures
New YorkSeed–Series A$1M – $30M
15 people
Siris
West Palm BeachGrowth–Late Stage$100M – $500M
18 people
TFX Capital
Fort MillPre-Seed–Series A$250K – $750K
15 people
Tusk Venture Partners
New YorkPre-Seed–Series A$750K – $2M
9 people
Related lists
Investors & VC Firms in North America (13488)Investors & VC Firms in United States (12527)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4707)AI & Machine Learning Investors & VC Firms (4538)Fintech Investors & VC Firms (4530)SaaS Investors & VC Firms (4205)Healthtech Investors & VC Firms (4177)Enterprise Software Investors & VC Firms (4092)Crypto & Web3 Investors & VC Firms (3961)
Data sourced from public filings and firms' own websites — see our methodology.













































































































